PD-L1 upregulation by lytic induction of Epstein-Barr Virus - ScienceDirect
Por um escritor misterioso
Descrição
PD-L1 upregulation by lytic induction of Epstein-Barr Virus - ScienceDirect
Advancing therapeutic strategies for Epstein-Barr virus-associated malignancies through lytic reactivation - ScienceDirect
Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule Inhibitors: Trends in Molecular Medicine
Rapid single-cell identification of Epstein–Barr virus-specific T-cell receptors for cellular therapy - Cytotherapy
(PDF) Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer
The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy: Trends in Immunology
RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells - ScienceDirect
CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease: Molecular Therapy - Oncolytics
Epstein-Barr virus—recent advances - The Lancet Infectious Diseases
Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
